Literature DB >> 23281213

Characterization of a psoriatic skin model produced with involved or uninvolved cells.

Jessica Jean1,2, Marie Leroy1,3, Alexandra Duque-Fernandez1,2, Geneviève Bernard1, Jacques Soucy4, Roxane Pouliot1,2.   

Abstract

Current knowledge suggests that uninvolved psoriatic skin could demonstrate characteristics associated with both normal and involved psoriatic skins. However, the triggering factor allowing the conversion of uninvolved skin into a psoriatic plaque is not fully understood. To counter this lack of information, we decided to develop pathological skin substitutes produced with uninvolved psoriatic cells, in order to better characterize the uninvolved psoriatic skin. Substitutes were produced using the self-assembly approach. Macroscopic, immunohistochemical, permeability and physicochemical results showed that involved substitutes had a thicker epidermis, higher cell proliferation, abnormal cell differentiation and a more permeable and disorganized stratum corneum compared with normal substitutes. Various results were observed using uninvolved cells, leading to two proposed profiles: profile 1 was suggested for uninvolved skin substitutes mimicking the results obtained with normal skin substitutes; and profile 2 was dedicated to those mimicking involved skin substitutes in all aspects that were analysed. In summary, uninvolved substitutes of profile 1 had a thin, well-organized epidermis with normal cell proliferation and differentiation, such as observed with normal substitutes, while uninvolved substitutes of profile 2 showed an inverse trend, i.e. a thicker epidermis, higher cell proliferation, abnormal cell differentiation and a more disorganized and more permeable stratum corneum, such as seen with involved substitutes. The results suggest that uninvolved substitutes could demonstrate characteristics associated with both normal or involved psoriatic skins.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Keywords:  in vitro models; lipid organization; permeability; psoriasis; skin substitutes

Mesh:

Year:  2012        PMID: 23281213     DOI: 10.1002/term.1666

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  5 in total

1.  Characterization of Epidermal Lipoxygenase Expression in Normal Human Skin and Tissue-Engineered Skin Substitutes.

Authors:  Carolyne Simard-Bisson; Lorraine Andrée Parent; Véronique J Moulin; Bernard Fruteau de Laclos
Journal:  J Histochem Cytochem       Date:  2018-07-09       Impact factor: 2.479

2.  Antipsoriatic Potential of Quebecol and Its Derivatives.

Authors:  Corinne Bouchard; Alexe Grenier; Sébastien Cardinal; Sarah Bélanger; Normand Voyer; Roxane Pouliot
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

Review 3.  Engineering Tissues without the Use of a Synthetic Scaffold: A Twenty-Year History of the Self-Assembly Method.

Authors:  Ingrid Saba; Weronika Jakubowska; Stéphane Bolduc; Stéphane Chabaud
Journal:  Biomed Res Int       Date:  2018-03-08       Impact factor: 3.411

4.  The Tissue-Engineered Human Psoriatic Skin Substitute: A Valuable In Vitro Model to Identify Genes with Altered Expression in Lesional Psoriasis.

Authors:  Geneviève Rioux; Claudia Pouliot-Bérubé; Mélissa Simard; Manel Benhassine; Jacques Soucy; Sylvain L Guérin; Roxane Pouliot
Journal:  Int J Mol Sci       Date:  2018-09-26       Impact factor: 5.923

5.  Dihydrochalcone Derivatives from Populus balsamifera L. Buds for the Treatment of Psoriasis.

Authors:  Audrey Bélanger; Alexe Grenier; François Simard; Isabelle Gendreau; André Pichette; Jean Legault; Roxane Pouliot
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.